目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Technology
1.2.2. Pathogen
1.2.3. End Use
1.2.4. Regional Scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Regional outlook
2.4. Competitive Insights

Chapter 3. Antimicrobial Resistance Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increase in risk of developing drug - resistant bacterial infections
3.2.1.2. Introduction of novel technologies to diagnose AMR infections
3.2.1.3. Favorable government initiatives
3.2.2. Market Restraint Analysis
3.2.2.1. Presence of stringent rules and regulations pertaining to diagnostics
3.3. Antimicrobial Resistance Diagnostics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape

Chapter 4. Antimicrobial Resistance Diagnostics Market: Technology Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Antimicrobial Resistance Diagnostics Market: Technology Movement Analysis
4.3. Antimicrobial Resistance Diagnostics Market by Technology Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. Microbiology Culture
4.5.1. Microbiology Culture Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Immunoassay
4.6.1. Immunoassay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.2. PCR
4.6.2.1. PCR Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.3. NGS
4.6.3.1. NGS Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.4. Mass Spectrometry
4.6.4.1. Mass Spectrometry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.5. Rapid & Point of Care
4.6.5.1. Rapid & Point of Care Assays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.6. Others
4.6.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Antimicrobial Resistance Diagnostics Market: Pathogen Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Antimicrobial Resistance Diagnostics Market: Pathogen Movement Analysis
5.3. Antimicrobial Resistance Diagnostics Market by Pathogen Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Drug Resistant Streptococcus Pneumoniae (DRSP)
5.5.1. Drug Resistant Streptococcus Pneumoniae (DRSP) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Drug Resistant Campylobacter (DRC)
5.6.1. Drug Resistant Campylobacter (DRC) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Clostridium Difficile (CD)
5.7.1. Clostridium Difficile (CD) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Drug Resistant Neisseria Gonorrhoeae (DRNG)
5.8.1. Drug Resistant Neisseria Gonorrhoeae (DRNG) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9. Drug Resistant Salmonella (DRNTS)
5.9.1. Drug Resistant Salmonella (DRNTS) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.10. Others
5.10.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Antimicrobial Resistance Diagnostics Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Antimicrobial Resistance Diagnostics Market: End Use Movement Analysis
6.3. Antimicrobial Resistance Diagnostics Market by End Use Outlook (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. Hospitals
6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Diagnostic Laboratories
6.6.1. Diagnostic Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Pharmaceutical & Biotechnology Companies
6.7.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Others
6.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Antimicrobial Resistance Diagnostics Market: Regional Estimates & Trend Analysis
7.1. Regional Dashboard
7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.3. North America
7.3.1. U.S.
7.3.1.1. Key country dynamics
7.3.1.2. Regulatory framework/ reimbursement structure
7.3.1.3. Competitive scenario
7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.3.2. Canada
7.3.2.1. Key country dynamics
7.3.2.2. Regulatory framework/ reimbursement structure
7.3.2.3. Competitive scenario
7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.3.3. Mexico
7.3.3.1. Key country dynamics
7.3.3.2. Regulatory framework/ reimbursement structure
7.3.3.3. Competitive scenario
7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework/ reimbursement structure
7.4.1.3. Competitive scenario
7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.4.2. Germany
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework/ reimbursement structure
7.4.2.3. Competitive scenario
7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.4.3. France
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework/ reimbursement structure
7.4.3.3. Competitive scenario
7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
7.4.4. Italy
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework/ reimbursement structure
7.4.4.3. Competitive scenario
7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.4.5. Spain
7.4.5.1. Key country dynamics
7.4.5.2. Regulatory framework/ reimbursement structure
7.4.5.3. Competitive scenario
7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.4.6. Norway
7.4.6.1. Key country dynamics
7.4.6.2. Regulatory framework/ reimbursement structure
7.4.6.3. Competitive scenario
7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.4.7. Sweden
7.4.7.1. Key country dynamics
7.4.7.2. Regulatory framework/ reimbursement structure
7.4.7.3. Competitive scenario
7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.4.8. Denmark
7.4.8.1. Key country dynamics
7.4.8.2. Regulatory framework/ reimbursement structure
7.4.8.3. Competitive scenario
7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. China
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
7.5.3. India
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/ reimbursement structure
7.5.3.3. Competitive scenario
7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
7.5.4. Australia
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework/ reimbursement structure
7.5.4.3. Competitive scenario
7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.5.5. South Korea
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework/ reimbursement structure
7.5.5.3. Competitive scenario
7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.5.6. Thailand
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework/ reimbursement structure
7.5.6.3. Competitive scenario
7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. Argentina
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. UAE
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.7.4. Kuwait
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Recent Developments & Impact Analysis by Key Market Participants
8.3. Company Market Share Analysis, 2024
8.4. Key Company Profiles
8.4.1. bioMerieux
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. F. Hoffmann - La Roche Ltd
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Abbott
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. BD
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Danaher
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Accelerate Diagnostics, Inc.
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Molsid
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Vela Diagnostics
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Visby Medical, Inc.
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. Hologic, Inc.
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives

List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Antimicrobial Resistance Diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 4 Global Antimicrobial Resistance Diagnostics market, by Pathogen, 2018 - 2030 (USD Million)
Table 5 Global Antimicrobial Resistance Diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 6 North America Antimicrobial Resistance Diagnostics market, by region, 2018 - 2030 (USD Million)
Table 7 North America Antimicrobial Resistance Diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 8 North America Antimicrobial Resistance Diagnostics market, by Pathogen, 2018 - 2030 (USD Million)
Table 9 North America Antimicrobial Resistance Diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 10 U.S Antimicrobial Resistance Diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 11 U.S Antimicrobial Resistance Diagnostics market, by Pathogen, 2018 - 2030 (USD Million)
Table 12 U.S Antimicrobial Resistance Diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 13 Mexico Antimicrobial Resistance Diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 14 Mexico Antimicrobial Resistance Diagnostics market, by Pathogen, 2018 - 2030 (USD Million)
Table 15 Mexico Antimicrobial Resistance Diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 16 Canada Antimicrobial Resistance Diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 17 Canada Antimicrobial Resistance Diagnostics market, by Pathogen, 2018 - 2030 (USD Million)
Table 18 Canada Antimicrobial Resistance Diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 19 Europe Antimicrobial Resistance Diagnostics market, by country, 2018 - 2030 (USD Million)
Table 20 Europe Antimicrobial Resistance Diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 21 Europe Antimicrobial Resistance Diagnostics market, by Pathogen, 2018 - 2030 (USD Million)
Table 22 Europe Antimicrobial Resistance Diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 23 UK Antimicrobial Resistance Diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 24 UK Antimicrobial Resistance Diagnostics market, by Pathogen, 2018 - 2030 (USD Million)
Table 25 UK Antimicrobial Resistance Diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 26 Germany Antimicrobial Resistance Diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 27 Germany Antimicrobial Resistance Diagnostics market, by Pathogen, 2018 - 2030 (USD Million)
Table 28 Germany Antimicrobial Resistance Diagnostics market, by End Use 2018 - 2030 (USD Million)
Table 29 France Antimicrobial Resistance Diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 30 France Antimicrobial Resistance Diagnostics market, by Pathogen, 2018 - 2030 (USD Million)
Table 31 France Antimicrobial Resistance Diagnostics market, by End Use 2018 - 2030 (USD Million)
Table 32 Italy Antimicrobial Resistance Diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 33 Italy Antimicrobial Resistance Diagnostics market, by Pathogen, 2018 - 2030 (USD Million)
Table 34 Italy Antimicrobial Resistance Diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 35 Spain Antimicrobial Resistance Diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 36 Spain Antimicrobial Resistance Diagnostics market, by Pathogen, 2018 - 2030 (USD Million)
Table 37 Spain Antimicrobial Resistance Diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 38 Denmark Antimicrobial Resistance Diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 39 Denmark Antimicrobial Resistance Diagnostics market, by Pathogen, 2018 - 2030 (USD Million)
Table 40 Denmark Antimicrobial Resistance Diagnostics market, by End Use 2018 - 2030 (USD Million)
Table 41 Norway Antimicrobial Resistance Diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 42 Norway Antimicrobial Resistance Diagnostics market, by Pathogen, 2018 - 2030 (USD Million)
Table 43 Norway Antimicrobial Resistance Diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 44 Sweden Antimicrobial Resistance Diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 45 Sweden Antimicrobial Resistance Diagnostics market, by Pathogen, 2018 - 2030 (USD Million)
Table 46 Sweden Antimicrobial Resistance Diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Antimicrobial Resistance Diagnostics market, by country, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Antimicrobial Resistance Diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 49 Asia Pacific Antimicrobial Resistance Diagnostics market, by Pathogen, 2018 - 2030 (USD Million)
Table 50 Asia Pacific Antimicrobial Resistance Diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 51 Japan Antimicrobial Resistance Diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 52 Japan Antimicrobial Resistance Diagnostics market, by Pathogen, 2018 - 2030 (USD Million)
Table 53 Japan Antimicrobial Resistance Diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 54 China Antimicrobial Resistance Diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 55 China Antimicrobial Resistance Diagnostics market, by Pathogen 2018 - 2030 (USD Million)
Table 56 China Antimicrobial Resistance Diagnostics market, by End Use 2018 - 2030 (USD Million)
Table 57 India Antimicrobial Resistance Diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 58 India Antimicrobial Resistance Diagnostics market, by Pathogen, 2018 - 2030 (USD Million)
Table 59 India Antimicrobial Resistance Diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 60 Australia Antimicrobial Resistance Diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 61 Australia Antimicrobial Resistance Diagnostics market, by Pathogen, 2018 - 2030 (USD Million)
Table 62 Australia Antimicrobial Resistance Diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 63 South Korea Antimicrobial Resistance Diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 64 South Korea Antimicrobial Resistance Diagnostics market, by Pathogen, 2018 - 2030 (USD Million)
Table 65 South Korea Antimicrobial Resistance Diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 66 Thailand Antimicrobial Resistance Diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 67 Thailand Antimicrobial Resistance Diagnostics market, by Pathogen, 2018 - 2030 (USD Million)
Table 68 Thailand Antimicrobial Resistance Diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 69 Latin America Antimicrobial Resistance Diagnostics market, by country, 2018 - 2030 (USD Million)
Table 70 Latin America Antimicrobial Resistance Diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 71 Latin America Antimicrobial Resistance Diagnostics market, by Pathogen, 2018 - 2030 (USD Million)
Table 72 Latin America Antimicrobial Resistance Diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 73 Brazil Antimicrobial Resistance Diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 74 Brazil Antimicrobial Resistance Diagnostics market, by Pathogen, 2018 - 2030 (USD Million)
Table 75 Brazil Antimicrobial Resistance Diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 76 Argentina Antimicrobial Resistance Diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 77 Argentina Antimicrobial Resistance Diagnostics market, by Pathogen, 2018 - 2030 (USD Million)
Table 78 Argentina Antimicrobial Resistance Diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 79 Middle East & Africa Antimicrobial Resistance Diagnostics market, by country, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa Antimicrobial Resistance Diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa Antimicrobial Resistance Diagnostics market, by Pathogen, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa Antimicrobial Resistance Diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 83 South Africa Antimicrobial Resistance Diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 84 South Africa Antimicrobial Resistance Diagnostics market, by Pathogen, 2018 - 2030 (USD Million)
Table 85 South Africa Antimicrobial Resistance Diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia Antimicrobial Resistance Diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia Antimicrobial Resistance Diagnostics market, by Pathogen, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia Antimicrobial Resistance Diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 89 UAE Antimicrobial Resistance Diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 90 UAE Antimicrobial Resistance Diagnostics market, by Pathogen, 2018 - 2030 (USD Million)
Table 91 UAE Antimicrobial Resistance Diagnostics market, by End Use, 2018 - 2030 (USD Million)
Table 92 Kuwait Antimicrobial Resistance Diagnostics market, by Technology, 2018 - 2030 (USD Million)
Table 93 Kuwait Antimicrobial Resistance Diagnostics market, by Pathogen, 2018 - 2030 (USD Million)
Table 94 Kuwait Antimicrobial Resistance Diagnostics market, by End Use, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Information procurement
Fig. 2 Primary research pattern
Fig. 3 Market research approaches
Fig. 4 Value chain-based sizing & forecasting
Fig. 5 Market formulation & validation
Fig. 6 Antimicrobial Resistance Diagnostics market segmentation
Fig. 7 Market driver analysis (current & future impact)
Fig. 8 Market restraint analysis (current & future impact)
Fig. 9 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 10 Porter’s five forces analysis
Fig. 11 Antimicrobial resistance diagnostics market, Technology outlook key takeaways, 2024 & 2030 (USD Million)
Fig. 12 Antimicrobial resistance diagnostics market: Pathogen movement analysis, 2024 & 2030 (USD Million)
Fig. 13 Antimicrobial resistance diagnostics market: end use movement analysis, 2024 & 2030 (USD Million)
Fig. 14 Microbiology Culture market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 15 Immunoassay market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 16 PCR market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 17 NGS market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 Mass Spectrometry market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Rapid & Point of Care market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Drug Resistant Streptococcus Pneumoniae market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Drug Resistant Campylobacter market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Clostridium Difficile market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Methicillin Resistant Staphylococcus Aureus market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Drug Resistant Neisseria Gonorrhoeae market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Drug Resistant Salmonella market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Hospitals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Diagnostic Laboratories market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Pharmaceutical & Biotechnology Companies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 North America antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 US antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Canada antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Mexico antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Europe antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 UK antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Germany antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 France antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Spain antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Italy antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Norway antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Denmark antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Sweden antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Asia Pacific antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 China antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Japan antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 India antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 South Korea antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Australia antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Thailand antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Latin America antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Brazil antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Argentina antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Middle East and Africa antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 South Africa antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Saudi Arabia antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 UAE antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Kuwait antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 List of key emerging company’s/Allergen disruptors/innovators